MedTech M&A Surge Continues In 2011 Following 95% Jump In 2010
This article was originally published in The Gray Sheet
Executive Summary
Merger and acquisition activity among U.S. and European medical technology firms roughly doubled in 2010 to a total of $30.6 billion and remained heated through the first half of 2011, according to a report from consulting firm Ernst & Young.
You may also be interested in...
MedTech’s New Normal: More Regulatory, Pricing Pressures And Challenging Financing Climate
Sustaining innovation in the current policy and financing environment may require new strategies from device companies focused not just on developing new products but on expanding into new kinds of offerings, including services and “holistic” solutions, Ernst & Young concludes in a recent report.
MedTech’s New Normal: More Regulatory, Pricing Pressures And Challenging Financing Climate
Sustaining innovation in the current policy and financing environment may require new strategies from device companies focused not just on developing new products but on expanding into new kinds of offerings, including services and “holistic” solutions, Ernst & Young concludes in a recent report.
J&J Doubles Down On Orthopedics With Synthes Deal; Takes Lead In Trauma
Johnson & Johnson will control a majority of the orthopedic trauma device market and double its stake in the spinal device field by acquiring Synthes for $21.3 billion under a definitive agreement announced April 27.